Skip to content

Bioavailability of Green Tea and Coffee Polyphenols

Bioavailability of Green Tea and Coffee Polyphenols in Healthy Participants

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03248115
Acronym
POBAS
Enrollment
11
Registered
2017-08-14
Start date
2013-04-10
Completion date
2013-10-18
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dietary Supplements, Diet, Food, and Nutrition

Keywords

polyphenols, green tea catechins, coffee caffeoylquinic acids, metabolism, inter-individual variability, colonic microbiota

Brief summary

There is little information on the dietary intake, absorption, metabolism and bioavailability (degree to which a substance becomes available to the target tissues upon administration) of polyphenols (natural substances present in a variety of foods) in human participants. This study assessed the bioavailability in healthy participants of polyphenols from 2 supplements containing green tea and green coffee extracts. Eleven participants were recruited and their habitual diet was assessed to estimate polyphenol intake. After completing a 24-hour urine collection, participants were given six green tea extract and three green coffee extract tablets, which they took daily for a period of 8 weeks. No tablets were taken during the last 4 weeks of the study. Further 24-hour urines were collected at 2, 4, 8 and 12 weeks. Participants were required to attend HNR (medical laboratory) the day after each 24hour urine collection. At these visits, they were asked to bring along their urine collections, completed documents (urine collection sheet, checklist for tablet intake/side effects) and any remaining supplements, which were used to assess tablet compliance. The investigators identified and quantified the amount of polyphenols in the supplement tablets as well as the amount of polyphenols and their metabolites in urine. The investigators then evaluated polyphenol bioavailability from the relationship between their dietary intake and urinary output. Evidence from this research could inform future intervention studies by providing data on the bioavailability of green tea and coffee polyphenols, and on the individual differences related to phenolic intake.

Interventions

DIETARY_SUPPLEMENTGreen tea and green coffee extract tablets

1. Tablets: participants were required to take 6 green tea and 3 green coffee extract tablets daily for a period of 8 weeks. No tablets were taken during the last 4 weeks of the study. Randomly chosen tablets were analysed to quantify their polyphenol content. 2. Urine collections: Several urine collections were required during the supplementation period in order have sufficient time points to estimate the plateau of the concentration of green tea and coffee polyphenols excreted in the urine to then be able to determine their bioavailability. There was a total of five 24-hour urine collections (at week 0 -before supplementation-, 2, 4, 8, and 12 -4 weeks after finishing the supplementation period). 3. Completion of study documents: Participants were provided with urine collection sheets, polyphenol questionnaires, checklists to record polyphenol tablet intake, and detailed instructions.

Sponsors

MRC Human Nutrition Research
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy men and women. * 18-45 years of age. * BMI between 18.5 and 24.9 kg/m2.

Exclusion criteria

* Smoking. * Allergy or intolerance to intervention supplements. * Chronic, acute or active inflammatory conditions, haematological disorders, or any other systemic illness of renal, hepatic or gastrointestinal origin. * Major surgical operations in the gastrointestinal tract or medical treatment for gastrointestinal problems. * Active cancer or diagnosis of malignancy within the last five years. * Pregnant, lactating, contemplating pregnancy.

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline phenolic metabolites in urine at 2 weeksWeek 0 -before supplementation- and week 2Assessment of the profile of metabolites coming from green tea and green coffee phytochemicals in urine
Change from baseline phenolic metabolites in urine at 4 weeksWeek 0 -before supplementation- and week 4Assessment of the profile of metabolites coming from green tea and green coffee
Change from baseline phenolic metabolites in urine at 8 weeksWeek 0 -before supplementation- and week 8Assessment of the profile of metabolites coming from green tea and green coffee
Change from baseline phenolic metabolites in urine at 12 weeksWeek 0 -before supplementation- and week 12 -4 weeks after finishing the supplementation period-Assessment of the profile of metabolites coming from green tea and green coffee

Secondary

MeasureTime frameDescription
Phenolic compounds in tabletsThrough study completion, an average of 3 monthsQuantification of the tablet polyphenol content

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026